Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?
作者信息
Colombo M P, Rodolfo M
机构信息
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milano, Italy.
出版信息
Cancer Immunol Immunother. 1995 Nov;41(5):265-70. doi: 10.1007/BF01517213.
Abstract
摘要
相似文献
1
Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?经工程改造以产生细胞因子或辅助因子作为细胞疫苗的肿瘤细胞：动物研究真的支持临床试验吗？
Cancer Immunol Immunother. 1995 Nov;41(5):265-70. doi: 10.1007/BF01517213.
2
Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines.细胞因子基因转导肿瘤细胞疫苗临床开发的考量因素
Methods. 1997 Jun;12(2):143-53. doi: 10.1006/meth.1997.0463.
3
Gene therapy of cancer by vaccines carrying inserted immunostimulatory genes.
Folia Biol (Praha). 2007;53(3):71-3.
4
Immunomodulation of cancer: potential use of selectively replicating agents.癌症的免疫调节：选择性复制剂的潜在用途。
J Clin Invest. 2000 May;105(9):1173-6. doi: 10.1172/JCI10026.
5
Cytokine gene-modified cell-based cancer vaccines.
Methods Mol Med. 2002;69:233-57. doi: 10.1385/1-59259-141-8:233.
6
Clinical application of immunostimulatory gene transfer.
Eur J Cancer. 1994;30A(8):1187-90. doi: 10.1016/0959-8049(94)90481-2.
7
Cytokine gene-engineered vaccines.
Curr Opin Mol Ther. 1999 Feb;1(1):34-8.
8
The potential applications of gene transfer in the treatment of patients with cancer: a concise review.
Cancer Invest. 1996;14(4):343-52. doi: 10.3109/07357909609012162.
9
[Application of gene therapy to antitumoral vaccination].[基因疗法在抗肿瘤疫苗接种中的应用]
Bull Cancer. 1995 Mar;82(3):228-32.
10
Genetically modified tumour vaccines--where we are today.转基因肿瘤疫苗——我们目前的进展
Cancer Treat Rev. 1999 Feb;25(1):29-46. doi: 10.1053/ctrv.1998.0104.
引用本文的文献
1
Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.共表达白细胞介素-12和核心蛋白聚糖的溶瘤腺病毒克服调节性T细胞介导的免疫抑制，在弱免疫原性肿瘤模型中诱导强大的抗肿瘤作用。
Oncotarget. 2017 Jan 17;8(3):4730-4746. doi: 10.18632/oncotarget.13972.
2
Antitumor immunity induced by irradiated tumor cells producing macrophage colony-stimulating factor.由产生巨噬细胞集落刺激因子的经辐照肿瘤细胞诱导的抗肿瘤免疫。
Int J Hematol. 2001 Apr;73(3):378-82. doi: 10.1007/BF02981965.
3
Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12.用经修饰以表达小鼠白细胞介素12的自体肿瘤细胞对Lewis肺癌进行抗转移疫苗接种。
Clin Exp Metastasis. 1998 Oct;16(7):623-32. doi: 10.1023/a:1006508413070.
本文引用的文献
1
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.体外负载可溶性蛋白的小鼠树突状细胞在体内可启动针对肿瘤抗原的细胞毒性T淋巴细胞。
J Exp Med. 1996 Jan 1;183(1):317-22. doi: 10.1084/jem.183.1.317.
2
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.巨噬细胞吞噬外源性抗原后主要组织相容性复合体I类分子对外源性抗原的高效呈递。
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4942-6. doi: 10.1073/pnas.90.11.4942.
3
Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.白细胞介素2、白细胞介素4、白细胞介素7、肿瘤坏死因子或干扰素γ的肿瘤细胞靶向基因转移诱导的排斥机制。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2774-8. doi: 10.1073/pnas.90.7.2774.
4
T cell clones specific for p21 ras-derived peptides: characterization of their fine specificity and HLA restriction.针对p21 ras衍生肽的T细胞克隆：其精细特异性和HLA限制的特征
Eur J Immunol. 1993 Mar;23(3):754-60. doi: 10.1002/eji.1830230328.
5
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.体外诱导人细胞毒性T淋巴细胞对突变型和野生型p53肽段的反应。
Eur J Immunol. 1993 Sep;23(9):2072-7. doi: 10.1002/eji.1830230905.
6
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.酪氨酸酶基因编码一种抗原，该抗原可被HLA - A2黑色素瘤上的自体细胞溶解性T淋巴细胞识别。
J Exp Med. 1993 Aug 1;178(2):489-95. doi: 10.1084/jem.178.2.489.
7
Immunization with interleukin-2 transfected melanoma cells. A phase I-II study in patients with metastatic melanoma.白细胞介素-2转染的黑色素瘤细胞免疫疗法。转移性黑色素瘤患者的I-II期研究。
Hum Gene Ther. 1993 Jun;4(3):323-30. doi: 10.1089/hum.1993.4.3-323.
8
Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide.通过用突变型ras肽进行初次体外免疫引发的特异性细胞毒性T淋巴细胞对ras癌基因转化细胞的裂解作用。
J Exp Med. 1994 Feb 1;179(2):473-9. doi: 10.1084/jem.179.2.473.
9
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.黑色素瘤中DNA-脂质体复合物介导的直接基因转移：在人体中的表达、生物学活性及无毒性
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11307-11. doi: 10.1073/pnas.90.23.11307.
10
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.应激诱导蛋白gp96、hsp90和hsp70的肿瘤特异性免疫原性比较。
J Immunol. 1994 Jun 1;152(11):5398-403.
Zotero 插件